SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-020971
Filing Date
2018-04-17
Accepted
2018-04-17 17:08:47
Documents
83
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tv491101_10k.htm 10-K 1195374
2 EXHIBIT 10.69 tv491101_ex10-69.htm EX-10.69 445202
3 EXHIBIT 21.1 tv491101_ex21-1.htm EX-21.1 2407
4 EXHIBIT 23.1 tv491101_ex23-1.htm EX-23.1 2357
5 EXHIBIT 31.1 tv491101_ex31-1.htm EX-31.1 10245
6 EXHIBIT 32.1 tv491101_ex32-1.htm EX-32.1 5332
13 GRAPHIC tv491101_ex10-69img1.jpg GRAPHIC 155574
  Complete submission text file 0001144204-18-020971.txt   10732459

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nwbo-20171231.xml EX-101.INS 2647956
8 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20171231.xsd EX-101.SCH 83946
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20171231_cal.xml EX-101.CAL 55408
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20171231_def.xml EX-101.DEF 583114
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20171231_lab.xml EX-101.LAB 573518
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20171231_pre.xml EX-101.PRE 620477
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35737 | Film No.: 18759632
SIC: 2834 Pharmaceutical Preparations